These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 26799186)

  • 1. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering.
    Singh R; Kapur N; Mir H; Singh N; Lillard JW; Singh S
    Oncotarget; 2016 Feb; 7(6):7343-53. PubMed ID: 26799186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer.
    Ha HK; Lee W; Park HJ; Lee SD; Lee JZ; Chung MK
    Mol Med Rep; 2011; 4(3):419-24. PubMed ID: 21468586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of CXCL16/CXCR6 axis in the metastasis of human prostate cancer].
    Zhou WH; Hu WD; Wu ZQ; Zheng XM; Wang BC
    Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):947-51. PubMed ID: 20646641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.
    Lu Y; Wang J; Xu Y; Koch AE; Cai Z; Chen X; Galson DL; Taichman RS; Zhang J
    Mol Cancer Res; 2008 Apr; 6(4):546-54. PubMed ID: 18344492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro.
    Hu W; Liu Y; Zhou W; Si L; Ren L
    PLoS One; 2014; 9(6):e99056. PubMed ID: 24897301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells.
    Hu W; Zhen X; Xiong B; Wang B; Zhang W; Zhou W
    Cancer Sci; 2008 Jul; 99(7):1362-9. PubMed ID: 18452560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of CXCL16 and its receptor C-X-C chemokine receptor 6 in prostate cancer.
    Richardsen E; Ness N; Melbø-Jørgensen C; Johannesen C; Grindstad T; Nordbakken C; Al-Saad S; Andersen S; Dønnem T; Nordby Y; Bremnes RM; Busund LT
    Am J Pathol; 2015 Oct; 185(10):2722-30. PubMed ID: 26272362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.
    Meijer J; Ogink J; Kreike B; Nuyten D; de Visser KE; Roos E
    Cancer Res; 2008 Jun; 68(12):4701-8. PubMed ID: 18559516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.
    Xiao G; Wang X; Wang J; Zu L; Cheng G; Hao M; Sun X; Xue Y; Lu J; Wang J
    Oncotarget; 2015 Jun; 6(16):14165-78. PubMed ID: 25909173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.
    Darash-Yahana M; Gillespie JW; Hewitt SM; Chen YY; Maeda S; Stein I; Singh SP; Bedolla RB; Peled A; Troyer DA; Pikarsky E; Karin M; Farber JM
    PLoS One; 2009 Aug; 4(8):e6695. PubMed ID: 19690611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of CXCL16/CXCR6 with carotid atherosclerosis in patients with metabolic syndrome.
    Lv Y; Hou X; Ti Y; Bu P
    Clin Nutr; 2013 Oct; 32(5):849-54. PubMed ID: 23398954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escin suppresses migration and invasion involving the alteration of CXCL16/CXCR6 axis in human gastric adenocarcinoma AGS cells.
    Lee HS; Hong JE; Kim EJ; Kim SH
    Nutr Cancer; 2014; 66(6):938-45. PubMed ID: 24911042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Escherichia coli in pathogenesis of xanthogranulomatous cholecystitis with scavenger receptor class A and CXCL16-CXCR6 interaction.
    Sawada S; Harada K; Isse K; Sato Y; Sasaki M; Kaizaki Y; Nakanuma Y
    Pathol Int; 2007 Oct; 57(10):652-63. PubMed ID: 17803654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the CXCL16/CXCR6 Pathway by Inflammation Contributes to Atherosclerosis in Patients with End-stage Renal Disease.
    Hu ZB; Chen Y; Gong YX; Gao M; Zhang Y; Wang GH; Tang RN; Liu H; Liu BC; Ma KL
    Int J Med Sci; 2016; 13(11):858-867. PubMed ID: 27877078
    [No Abstract]   [Full Text] [Related]  

  • 15. Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor.
    Yoon MS; Pham CT; Phan MT; Shin DJ; Jang YY; Park MH; Kim SK; Kim S; Cho D
    Cytotherapy; 2016 Dec; 18(12):1532-1542. PubMed ID: 27720639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas.
    Held-Feindt J; Rehmke B; Mentlein R; Hattermann K; Knerlich F; Hugo HH; Ludwig A; Mehdorn HM
    Glia; 2008 May; 56(7):764-74. PubMed ID: 18293410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.
    Guo L; Cui ZM; Zhang J; Huang Y
    Chin J Cancer; 2011 May; 30(5):336-43. PubMed ID: 21527066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma.
    Wente MN; Gaida MM; Mayer C; Michalski CW; Haag N; Giese T; Felix K; Bergmann F; Giese NA; Friess H
    Int J Oncol; 2008 Aug; 33(2):297-308. PubMed ID: 18636150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemokine, CXCL16, and its receptor, CXCR6, are constitutively expressed in human annulus fibrosus and expression of CXCL16 is up-regulated by exposure to IL-1ß in vitro.
    Gruber HE; Marrero E; Ingram JA; Hoelscher GL; Hanley EN
    Biotech Histochem; 2017; 92(1):7-14. PubMed ID: 27869573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CXCL16-CXCR6 chemokine axis in glial tumors.
    Hattermann K; Held-Feindt J; Ludwig A; Mentlein R
    J Neuroimmunol; 2013 Jul; 260(1-2):47-54. PubMed ID: 23628207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.